Dr Anthony Hodder
Honorary (Fellow)
Department of Medical Biology (WEHI)
76 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
MK-7602: a potent multi-stage dual-targeting antimalarial
DOI: 10.1016/j.ebiom.2025.1060612025
Journal article
Structure–activity analysis of imino-pyrimidinone-fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitors
DOI: 10.1111/febs.700382024
Journal article
Flp/FRT-mediated disruption of ptex150 and exp2 in Plasmodium falciparum sporozoites inhibits liver-stage development
DOI: 10.1073/pnas.24034421212022
Journal article
Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
DOI: 10.1002/cmdc.2022003062022
Journal article
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax
DOI: 10.1016/j.str.2022.03.0182020
Journal article
Structure of the Plasmodium falciparum PfSERA5 pseudo-zymogen
DOI: 10.1002/pro.39562019
Journal article
Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex
DOI: 10.1038/s41586-018-0779-6
RECENT SCHOLARLY WORKS
2018
Journal article
Antibodies to intercellular adhesion molecule 1-binding Plasmodium falciparum erythrocyte membrane protein 1-DBLβ are biomarkers of protective immunity to malaria in a cohort of young children from Papua New Guinea
DOI: 10.1128/IAI.00485-172018
Journal article
Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics
DOI: 10.1016/j.ejmech.2018.05.0222017
Journal article
Differing rates of antibody acquisition to merozoite antigens in malaria: Implications for immunity and surveillance
DOI: 10.1189/jlb.5MA0716-294R